Article
Aberrant NOVA1 function disrupts alternative splicing in early stages of amyotrophic lateral sclerosis
1 Jul 2022
Abstract excerpt
Amyotrophic lateral sclerosis (ALS) is a fatal disease characterized by aberrant alternative splicing (AS). Nuclear loss and cytoplasmic accumulation of the splicing factor TDP-43 in motor neurons (MN) are hallmarks of ALS at late stages of the disease. However, it is unknown if altered AS is present before TDP-43 pathology occurs. Here, we investigate altered AS and its origins in early stages of ALS using human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
